Researchers at University of California, Los Angeles had previously reported the development of a molecular compound called CLR01 that prevented toxic proteins associated with Parkinson's disease from binding together and killing the brain's neurons.
Using the same compound, dubbed a "molecular tweezer" in a living mouse model of Alzheimer's, researchers demonstrated that the compound safely crossed the blood
